The pharmacodynamic properties of fluproquazone.
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D001993:Bronchodilator Agents; D002490:Central Nervous System / Q000187:drug effects; D004285:Dogs; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D008297:Male; D051379:Mice; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000096:biosynthesis; D011799:Quinazolines / Q000494:pharmacology*; D052999:Quinazolinones; D011817:Rabbits; D051381:Rats; D013276:Stomach Ulcer / Q000139:chemically induced
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001993:Bronchodilator Agents; D011453:Prostaglandins; D011799:Quinazolines; D052999:Quinazolinones; C023491:fluproquazone